Ovid Therapeutics and Columbia University are Working on a Treatment for KIF1A Associated Neurological Disorder

According to a story from GlobeNewswire, the biopharmaceutical company Ovid Therapeutics Inc. and Columbia University have recently entered a collaborative partnership that will be focused on developing gene-based treatments for…

Continue Reading Ovid Therapeutics and Columbia University are Working on a Treatment for KIF1A Associated Neurological Disorder

KIF1A.ORG’s KIF1A Family & Scientific Conference

The KIF1A Family & Scientific Conference KIF1A.ORG is putting together its very first KIF1A focused family and science conference. This conference will be an unprecedented opportunity for KIF1A associated neurological…

Continue Reading KIF1A.ORG’s KIF1A Family & Scientific Conference